Conviction invests in Xlue: health world model beats frontier models in blind disease prediction

XiongChenyan · x · 2026-11-19

Conviction announced an investment in Xlue, arguing that today's models are excellent academics—having read every paper—but still can't predict when you'll fall sick or which treatment will work. Xlue treats health as a world-model problem rather than next-token prediction; in a third-party double-blind disease prediction study, its Xlue Health World Model substantially outperformed frontier models including Astra.

Original post →

More from Research

Research channel →